Terns Pharmaceuticals Inc TERN Balance Sheet

Income Statement

Quarter End	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	192.59M	287.03M	301.29M	289.7M	271.69M	268.52M	246.77M	230.88M
Total Current Assets	190.54M	285.19M	299.66M	288.32M	270.46M	267.43M	245.9M	230.24M
Cash and Equivalents	62.98M	143.24M	184.35M	80.92M	37.89M	79.93M	65.1M	91.5M
Total Non-Current Assets	2.05M	2.6M	1.62M	1.38M	1.23M	1.59M	871k	642k
Total Liabilities	8.89M	10.08M	13.6M	15.55M	13.26M	13.15M	10.05M	12.2M
Total Current Liabilities	7.48M	8.47M	12.11M	14.24M	12.09M	11.94M	8.83M	10.96M
Total Non-Current Liabilities	1.41M	1.62M	1.49M	1.31M	1.18M	1.21M	1.22M	1.24M
Common Equity	4k	5k	5k	6k	6k	6k	6k	7k
Retained Earnings	-226.6M	-242.42M	-263.95M	-281.84M	-311.61M	-332.63M	-355M	-377.74M

Year End December 30 2023	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	89.07M	23.9M	92.29M	168.07M	287.03M	268.52M
Total Current Assets	88.48M	22.22M	90.87M	166.93M	285.19M	267.43M
Cash and Equivalents	82.52M	12.33M	74.85M	47.7M	143.24M	79.93M
Total Non-Current Assets	-22.74M	-90.76M	-117.44M	160.3M	276.94M	255.37M
Total Liabilities	16.84M	19.7M	23.7M	7.77M	10.08M	13.15M
Total Current Liabilities	2.38M	4.95M	22.82M	6.82M	8.47M	11.94M
Total Non-Current Liabilities	14.47M	14.75M	877k	947k	1.62M	1.21M
Total Equity	-22.74M	-90.76M	-117.44M	160.3M	276.94M	255.37M
Common Equity	0	0	0	3k	5k	6k
Retained Earnings	-23.25M	-91.86M	-131.92M	-338k	-242.42M	-332.63M